VI-1121 for the Treatment Alzheimer's Disease

NCT01428362 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: VI-1121
DRUG: Placebo

Sponsor

VIVUS LLC

Collaborators

[object Object]